ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

The N6-methyladenosine METTL3 regulates tumorigenesis and glycolysis by mediating m6A methylation of the tumor suppressor LATS1 in breast cancer

Xu, Youqin; Song, Mu; Hong, Ziyang; Chen, Wancheng; Zhang, Qianbing; Zhou, Jianlong; Yang, Chao; He, Zilong; Yu, Juanjuan; Peng, Xiaolin; Zhu, Qiuhong; Li, Shaotian; Ji, Kaiyuan*; Liu, Minfeng*; Zuo, Qiang*广州医学院; 南方医科大学
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH2023-1-7DOI: 10.1186/s13046-022-02581-1
15被引10阅读
引用收藏
分享

摘要

Background Posttranscriptional modification of tumor-associated factors plays a pivotal role in breast cancer progression. However, the underlying mechanism remains unknown. M6A modifications in cancer cells are dynamic and reversible and have been found to impact tumor initiation and progression through various mechanisms. In this study, we explored the regulatory mechanism of breast cancer cell proliferation and metabolism through m6A methylation in the Hippo pathway. Methods A combination of MeRIP-seq, RNA-seq and metabolomics-seq was utilized to reveal a map of m6A modifications in breast cancer tissues and cells. We conducted RNA pull-down assays, RIP-qPCR, MeRIP-qPCR, and RNA stability analysis to identify the relationship between m6A proteins and LATS1 in m6A regulation in breast cancer cells. The expression and biological functions of m6A proteins were confirmed in breast cancer cells in vitro and in vivo. Furthermore, we investigated the phosphorylation levels and localization of YAP/TAZ to reveal that the activity of the Hippo pathway was affected by m6A regulation of LATS1 in breast cancer cells. Results We demonstrated that m6A regulation plays an important role in proliferation and glycolytic metabolism in breast cancer through the Hippo pathway factor, LATS1. METTL3 was identified as the m6A writer, with YTHDF2 as the reader protein of LATS1 mRNA, which plays a positive role in promoting both tumorigenesis and glycolysis in breast cancer. High levels of m6A modification were induced by METTL3 in LATS1 mRNA. YTHDF2 identified m6A sites in LATS1 mRNA and reduced its stability. Knockout of the protein expression of METTL3 or YTHDF2 increased the expression of LATS1 mRNA and suppressed breast cancer tumorigenesis by activating YAP/TAZ in the Hippo pathway. Conclusions In summary, we discovered that the METTL3-LATS1-YTHDF2 pathway plays an important role in the progression of breast cancer by activating YAP/TAZ in the Hippo pathway.

学科与关键词

关键词
Breast cancerMETTL3LATS1Hippo-YAPTAZ signaling pathway
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
发表日期
2023-01-07
卷期
第 42 卷, 第 1 期
页码
10
DOI
10.1186/s13046-022-02581-1
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China; China Postdoctoral Science Foundation [81902865, 82002938, 82103378, 81872009]; Medical Science and Technology Research Foundation of Guangdong Province [2021M690073]; President's Fund of Nanfang Hospital, Southern Medical University [15-A2020510]; [2019C017]

作者

  • X

    Xu, Youqin (第一作者)

    southern med univ

  • S

    Song, Mu

    southern med univ

查看全部 15 位作者收起作者
  • H

    Hong, Ziyang

    southern med univ

  • C

    Chen, Wancheng

    southern med univ

  • Z

    Zhang, Qianbing

    southern med univ

  • Z

    Zhou, Jianlong

  • Y

    Yang, Chao

    southern med univ

  • H

    He, Zilong

    southern med univ

  • Y

    Yu, Juanjuan

    southern med univ

  • P

    Peng, Xiaolin

    southern med univ

  • Z

    Zhu, Qiuhong

    southern med univ

  • L

    Li, Shaotian

    southern med univ

  • J

    Ji, Kaiyuan (通讯)

    guangzhou med univ · guangzhou women & childrens med ctr

  • L

    Liu, Minfeng (通讯)

    southern med univ

  • Z

    Zuo, Qiang (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417